2nd Annual Oncology Clinical Development Congress
Over 150 delegates working in Oncology Clinical Development & Oncology Clinical Trials
Over 25 presentations, case studies and panel discussions delivered by leading biotech companies, global pharma organisations & internationally renowned academic institutions.
Including 2 interactive streams:
- Optimising Clinical Development in Oncology
- Executing Successful Oncology Clinical Trials
Co-located with the 3rd Annual Oncology Biomarkers Congress 2013
14 prescheduled one to one meetings, exhibition spaces and informal networking opportunities
Oxford Global Conferences are proud to present the 2nd Annual Oncology Clinical Development Congress which will be held on the 14th & 15th October 2013, at the Hilton Manchester Deansgate, UK.
It is estimated that each year 12.7million people are diagnosed with cancer across the globe. Our experts will discuss the latest advances in the development of targeted therapies and explore their translation into clinical trials.
There is much debate as to whether oncology therapies should increase the quality of life or the lifespan of the patient; join our renowned speakers in identifying appropriate clinical endpoints. On day one hear from industry leaders working at the forefront of oncology co-development. Topics for discussion include mechanisms of cancer drug resistance, strategies to reach critical go/no go decisions and novel imaging technologies.
On day two our distinguished speakers will explore case studies of global clinical trials, strategies to overcome operational challenges and methods to ensure effective patient recruitment and retention. Our experts will discuss approaches to reduce clinical timelines, cost of adaptive clinical trial designs and methods of methods of appropriate site selection.
Co-located with our 3rd Annual Oncology Biomarkers Congress, this event, attracting over 150 senior-level decision makers, is a must for anyone working in Oncology Clinical Development.